Table 3.
Proportion (95 % CI) of admissions with AEs classified according to type
Type | 2013 | 2014 | 2015 | 2016 |
Hospital-acquired infection | 5.2 (4.9 to 5.5) | 4.6 (4.3 to 4.9)* | 4.5 (4.1 to 4.8)* | 4.3 (4.0 to 4.7)* |
Infection other | 1.4 (1.2 to 1.6) | 1.0 (0.8 to 1.1)* | 1.1(0.9 to 1.3) | 0.9 (0.8 to 1.1)* |
Urinary tract infection | 1.4 (1.3 to 1.6) | 1.5 (1.4 to 1.7) | 1.3 (1.1 to 1.5) | 1.3 (1.1 to 1.5) |
Postoperative wound infection | 1.2 (1.1 to 1.4) | 1.2 (1.0 to 1.3) | 1.1 (0.9 to 1.2) | 1.1 (0.9 to 1.3) |
Pneumonia | 0.7 (0.6 to 0.8) | 0.5 (0.4 to 0.6)* | 0.5 (0.4 to 0.6)* | 0.5 (0.4 to 0.6)* |
Sepsis | 0.5 (0.4 to 0.6) | 0.3 (0.3 to 0.4)* | 0.4 (0.3 to 0.6) | 0.5 (0.4 to 0.6) |
Central venous line infection | 0.2 (0.1 to 0.2) | 0.1 (0.0 to 0.1) | 0.1 (0.0 to 0.1) | 0.1 (0.0 to 0.2) |
Ventilator associated pneumonia | 0.1 (0.1 to 0.2) | 0.0 (0.0 to 0.1)* | 0.1 (0.0 to 0.1) | 0,1 (0,0 to 0.1)* |
Clostridium difficile infection | – | 0.3 (0.2 to 0.3) | 0.3 (0.2 to 0.3) | 0.3 (0.2 to 0.3) |
Other | 2.7 (2.5 to 3.0) | 2.4 (2.2 to 2.7) | 2.0 (1.8 to 2.3)* | 2.2 (2.0 to 2.5)* |
AEs caused by surgery/invasive procedures | 1.9 (1.7 to 2.1) | 1.8 (1.6 to 2.0) | 1.8 (1.6 to 2.0) | 1.6 (1.4 to 1.8) |
Urinary bladder distention | 1.7 (1.5 to 1.9) | 1.0 (0.9 to 1.2)* | 1.0 (0.9 to 1.2)* | 1.1 (0.9 to 1.3)* |
Drug-related AE | 1.4 (1.3 to 1.6) | 1.4 (1.2 to 1.6) | 1.3 (1.1 to 1.5) | 1.5 (1.3 to 1.7) |
Pressure ulcer (grades 2–4) | 1.1 (1.0 to 1.3) | 1.0 (0.9 to 1.1) | 1.2 (1.0 to 1.4) | 1.3 (1.1 to 1.5) |
Fall injury | 0.8 (0.7 to 0.9) | 0.9 (0.7 to 1.0) | 0.7 (0.5 to 0.8) | 0.7 (0.6 to 0.9) |
Compromised vital signs | 0.5 (0.4 to 0.6) | 0.3 (0.2 to 0.3)* | 0.3 (0.2 to 0.4) | 0.2 (0.1 to 0.2)* |
Postpartum or obstetric AE† | 0.2 (0.2 to 0.3) | 0.2 (0.2 to 0.3) | 0.1 (0.1 to 0.2)* | 0.3 (0.2 to 0.4) |
Neurological AE | 0.1 (0.1 to 0.2) | 0.0 (0.0 to 0.1) | 0.1 (0.0 to 0.1) | 0.1 (0.1 to 0.2) |
*Significant differences compared with 2013.
†Not corrected for the proportion of women in the studied population.
AEs, adverse events.